ES2055709T3 - Un procedimiento para preparar una composicion farmaceutica. - Google Patents

Un procedimiento para preparar una composicion farmaceutica.

Info

Publication number
ES2055709T3
ES2055709T3 ES87310551T ES87310551T ES2055709T3 ES 2055709 T3 ES2055709 T3 ES 2055709T3 ES 87310551 T ES87310551 T ES 87310551T ES 87310551 T ES87310551 T ES 87310551T ES 2055709 T3 ES2055709 T3 ES 2055709T3
Authority
ES
Spain
Prior art keywords
preparing
procedure
pharmaceutical composition
antihypertensive agent
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87310551T
Other languages
English (en)
Inventor
Robin Edwin Beecham Buckingham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629234A external-priority patent/GB8629234D0/en
Priority claimed from GB868630926A external-priority patent/GB8630926D0/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of ES2055709T3 publication Critical patent/ES2055709T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN PRODUCTO FARMACEUTICO QUE COMPRENDE UN AGENTE ANTIHIPERTENSIVO ACTIVADOR DE CONDUCTOS DE POTASIO Y UN AGENTE ANTIHIPERTENSIVO INHIBIDOR DE ACE COMO UNA PREPARACION COMBINADA PARA USO SIMULTANEO, SEPARADO O SECUENCIAL EN LA TERAPIA DE LA HIPERTENSION.
ES87310551T 1986-12-06 1987-11-30 Un procedimiento para preparar una composicion farmaceutica. Expired - Lifetime ES2055709T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629234A GB8629234D0 (en) 1986-12-06 1986-12-06 Pharmaceutical preparations
GB868630926A GB8630926D0 (en) 1986-12-24 1986-12-24 Pharmaceutical preparations

Publications (1)

Publication Number Publication Date
ES2055709T3 true ES2055709T3 (es) 1994-09-01

Family

ID=26291661

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87310551T Expired - Lifetime ES2055709T3 (es) 1986-12-06 1987-11-30 Un procedimiento para preparar una composicion farmaceutica.

Country Status (11)

Country Link
EP (1) EP0271271B1 (es)
KR (1) KR880007081A (es)
AT (1) ATE71535T1 (es)
AU (1) AU607728B2 (es)
CA (1) CA1305420C (es)
DE (1) DE3776111D1 (es)
DK (1) DK639887A (es)
ES (1) ES2055709T3 (es)
GR (1) GR3003599T3 (es)
NZ (1) NZ222806A (es)
PT (1) PT86292B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
DE3915236A1 (de) * 1989-05-10 1990-11-15 Merck Patent Gmbh Pharmazeutische zubereitung
GB8915315D0 (en) * 1989-07-04 1989-08-23 Sandoz Ltd Pharmaceutical compositions for use against hypertension and congestive heart failure
EP0555681A1 (en) * 1992-02-13 1993-08-18 E.R. SQUIBB & SONS, INC. Use of a combination of potassium channel activators and sulfhydryl containing compounds for the manufacture of a medicament for the treatment of ischemia and myocarolial infarct
SG49907A1 (en) * 1992-12-11 1998-06-15 Smithkline Beecham Corp Pharmaceutical composition containing bicyclic type compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419516D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment

Also Published As

Publication number Publication date
GR3003599T3 (es) 1993-03-16
DE3776111D1 (de) 1992-02-27
PT86292A (pt) 1988-01-01
AU8209987A (en) 1988-06-09
DK639887A (da) 1988-06-07
DK639887D0 (da) 1987-12-04
EP0271271B1 (en) 1992-01-15
ATE71535T1 (de) 1992-02-15
PT86292B (pt) 1990-11-07
AU607728B2 (en) 1991-03-14
CA1305420C (en) 1992-07-21
EP0271271A3 (en) 1989-11-15
NZ222806A (en) 1991-05-28
KR880007081A (ko) 1988-08-26
EP0271271A2 (en) 1988-06-15

Similar Documents

Publication Publication Date Title
ES2042776T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
PT83872A (de) Arzneimittel
NO862095L (no) Farmasoeytiske preparater inneholdende vevsplasmnogenaktivitator og fremgangsmaate for deres fremstilling.
ES555353A0 (es) Un procedimiento para preparar una formulacion farmaceutica liofilizada de activador de plasminogeno de tejidro (t-pa)
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
ES2055709T3 (es) Un procedimiento para preparar una composicion farmaceutica.
FR2735369B1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
IL92672A0 (en) Retroviral protease inhibitors,their preparation and pharmaceutical compositions containing them
ES542430A0 (es) Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio.
IS5390A (is) Bensoxazín og bensóþíazín afleiður og notkun þeirra í lyf
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
MX6424A (es) Derivados de tripeptidos, procedimientos para la preparacion de derivados de tripeptidos y composiciones que los contienen.
ATE81775T1 (de) Pharmazeutische zusammensetzungen.
DK163639C (da) Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper
DK284688D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
DK694188D0 (da) Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
AU580890B2 (en) P-acylaminobenzamides
DK163175C (da) Synergistisk farmaceutisk kombinationspraeparat af vaevs-plasminogenaktivator, t-pa, og oxypurinol
SE7806469L (sv) Antihypertensiva kompositioner
FI874823A0 (fi) Farmaceutisk komposition foer anvaendning mot hypertension och kongestiv hjaertinsufficiens.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 271271

Country of ref document: ES